Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Hallux
23052 Alcade Dr Ste A
Laguna Hills, CA 92653
http://halluxinc.com/

Hallux is developing an investigational micro-insert for subungual delivery and treatment of distal lateral subungual onychomycosis. The dosage form is biodegradable and delivers high concentrations of terbinafine hydrochloride directly and selectively to the site of infection over a period of time. Results from pilot studies are encouraging and suggest that the subungual treatment procedure is safe and well tolerated. Hallux is planning to further evaluate efficacy, safety, and tolerability in a series of single site clinical studies commencing in the first half of 2016.

Key Contact
Name
Mark Taylor
Title
CEO and Co-Founder
Funding Events

Date
Amount
Type
Investors
Valuation
12/17/15 $7,100,000 Series A Deerfield Management Company, L.P.
undisclosed


Featured Reading